MoneyWorks4Me

Shilpa Medicare informs about company updates

29 Jul 2019 Evaluate

Shilpa Medicare has informed that the Company has completed USFDA audit at its API site, Raichur between 22nd July 2019 and 26th July 2019. The Company has received Form 483 with 5 observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..